SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'LMR'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1G60_A_SAMA500_0 (ADENINE-SPECIFICMETHYLTRANSFERASEMBOIIA) |
3rrp | PROBABLE FUMARATEHYDRATASE FUM (Mycobacteroidesabscessus) | 5 / 12 | ASN A 367PHE A 97GLY A 100SER A 101THR A 103 | NoneNoneNoneLMR A 468 (-2.9A)LMR A 468 (-2.9A) | 1.33A | 1g60A-3rrpA:undetectable | 1g60A-3rrpA:18.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HTT_A_HISA450_0 (HISTIDYL-TRNASYNTHETASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 5 / 10 | GLU A 95GLN A 145TYR A 310TYR A 333GLY A 348 | LMR A 401 (-3.4A)LMR A 401 (-3.7A)NoneLMR A 401 (-4.1A)LMR A 401 (-3.4A) | 1.16A | 1httA-3racA:26.2 | 1httA-3racA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HTT_A_HISA450_0 (HISTIDYL-TRNASYNTHETASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 6 / 10 | GLU A 95THR A 97GLU A 149TYR A 310TYR A 311GLY A 331 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)LMR A 401 (-3.7A)NoneLMR A 401 (-4.5A)None | 0.99A | 1httA-3racA:26.2 | 1httA-3racA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HTT_A_HISA450_0 (HISTIDYL-TRNASYNTHETASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 7 / 10 | GLU A 95THR A 97TYR A 119ARG A 125GLN A 145GLU A 149GLY A 330 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)NoneNoneLMR A 401 (-3.7A)LMR A 401 (-3.7A)LMR A 401 (-3.5A) | 1.00A | 1httA-3racA:26.2 | 1httA-3racA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HTT_A_HISA450_0 (HISTIDYL-TRNASYNTHETASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 9 / 10 | GLU A 95THR A 97TYR A 119GLN A 145GLU A 149ARG A 306TYR A 310TYR A 311GLY A 330 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)NoneLMR A 401 (-3.7A)LMR A 401 (-3.7A)NoneNoneLMR A 401 (-4.5A)LMR A 401 (-3.5A) | 0.62A | 1httA-3racA:26.2 | 1httA-3racA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HTT_A_HISA450_0 (HISTIDYL-TRNASYNTHETASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 5 / 10 | TYR A 119ARG A 125GLN A 145GLU A 149TYR A 310 | NoneNoneLMR A 401 (-3.7A)LMR A 401 (-3.7A)None | 1.34A | 1httA-3racA:26.2 | 1httA-3racA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HTT_B_HISB450_0 (HISTIDYL-TRNASYNTHETASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 5 / 12 | GLU A 95GLN A 145TYR A 310TYR A 333GLY A 330 | LMR A 401 (-3.4A)LMR A 401 (-3.7A)NoneLMR A 401 (-4.1A)LMR A 401 (-3.5A) | 1.30A | 1httB-3racA:25.8 | 1httB-3racA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HTT_B_HISB450_0 (HISTIDYL-TRNASYNTHETASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 8 / 12 | GLU A 95THR A 97ARG A 125GLN A 145GLU A 149ARG A 306GLY A 330GLY A 348 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)NoneLMR A 401 (-3.7A)LMR A 401 (-3.7A)NoneLMR A 401 (-3.5A)LMR A 401 (-3.4A) | 0.95A | 1httB-3racA:25.8 | 1httB-3racA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HTT_B_HISB450_0 (HISTIDYL-TRNASYNTHETASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 8 / 12 | GLU A 95THR A 97ARG A 125GLN A 145GLU A 149ARG A 306TYR A 333GLY A 348 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)NoneLMR A 401 (-3.7A)LMR A 401 (-3.7A)NoneLMR A 401 (-4.1A)LMR A 401 (-3.4A) | 1.03A | 1httB-3racA:25.8 | 1httB-3racA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HTT_B_HISB450_0 (HISTIDYL-TRNASYNTHETASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 9 / 12 | GLU A 95THR A 97GLN A 145GLU A 149ARG A 306TYR A 310TYR A 311GLY A 330GLY A 348 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)LMR A 401 (-3.7A)LMR A 401 (-3.7A)NoneNoneLMR A 401 (-4.5A)LMR A 401 (-3.5A)LMR A 401 (-3.4A) | 0.57A | 1httB-3racA:25.8 | 1httB-3racA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HTT_B_HISB450_0 (HISTIDYL-TRNASYNTHETASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 9 / 12 | GLU A 95THR A 97GLN A 145GLU A 149ARG A 306TYR A 310TYR A 311TYR A 333GLY A 348 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)LMR A 401 (-3.7A)LMR A 401 (-3.7A)NoneNoneLMR A 401 (-4.5A)LMR A 401 (-4.1A)LMR A 401 (-3.4A) | 0.71A | 1httB-3racA:25.8 | 1httB-3racA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HTT_B_HISB450_0 (HISTIDYL-TRNASYNTHETASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 9 / 12 | THR A 97GLN A 145GLU A 149ARG A 306LEU A 308TYR A 310TYR A 311GLY A 330GLY A 348 | LMR A 401 (-3.5A)LMR A 401 (-3.7A)LMR A 401 (-3.7A)NoneNoneNoneLMR A 401 (-4.5A)LMR A 401 (-3.5A)LMR A 401 (-3.4A) | 0.46A | 1httB-3racA:25.8 | 1httB-3racA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HTT_B_HISB450_0 (HISTIDYL-TRNASYNTHETASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 9 / 12 | THR A 97GLN A 145GLU A 149ARG A 306LEU A 308TYR A 310TYR A 311TYR A 333GLY A 348 | LMR A 401 (-3.5A)LMR A 401 (-3.7A)LMR A 401 (-3.7A)NoneNoneNoneLMR A 401 (-4.5A)LMR A 401 (-4.1A)LMR A 401 (-3.4A) | 0.63A | 1httB-3racA:25.8 | 1httB-3racA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HTT_B_HISB450_0 (HISTIDYL-TRNASYNTHETASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 7 / 12 | THR A 97GLU A 149LEU A 308TYR A 310TYR A 311GLY A 331GLY A 348 | LMR A 401 (-3.5A)LMR A 401 (-3.7A)NoneNoneLMR A 401 (-4.5A)NoneLMR A 401 (-3.4A) | 1.17A | 1httB-3racA:25.8 | 1httB-3racA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HTT_C_HISC450_0 (HISTIDYL-TRNASYNTHETASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 6 / 12 | GLU A 95GLN A 145TYR A 310TYR A 333GLY A 330ALA A 350 | LMR A 401 (-3.4A)LMR A 401 (-3.7A)NoneLMR A 401 (-4.1A)LMR A 401 (-3.5A)LMR A 401 ( 3.9A) | 1.42A | 1httC-3racA:26.3 | 1httC-3racA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HTT_C_HISC450_0 (HISTIDYL-TRNASYNTHETASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 11 / 12 | GLU A 95THR A 97GLN A 145GLU A 149ARG A 306LEU A 308TYR A 310TYR A 311GLY A 330GLY A 348ALA A 350 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)LMR A 401 (-3.7A)LMR A 401 (-3.7A)NoneNoneNoneLMR A 401 (-4.5A)LMR A 401 (-3.5A)LMR A 401 (-3.4A)LMR A 401 ( 3.9A) | 0.52A | 1httC-3racA:26.3 | 1httC-3racA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HTT_C_HISC450_0 (HISTIDYL-TRNASYNTHETASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 11 / 12 | GLU A 95THR A 97GLN A 145GLU A 149ARG A 306LEU A 308TYR A 310TYR A 311TYR A 333GLY A 348ALA A 350 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)LMR A 401 (-3.7A)LMR A 401 (-3.7A)NoneNoneNoneLMR A 401 (-4.5A)LMR A 401 (-4.1A)LMR A 401 (-3.4A)LMR A 401 ( 3.9A) | 0.71A | 1httC-3racA:26.3 | 1httC-3racA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HTT_C_HISC450_0 (HISTIDYL-TRNASYNTHETASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 8 / 12 | GLU A 95THR A 97GLU A 149LEU A 308TYR A 310TYR A 311GLY A 331GLY A 348 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)LMR A 401 (-3.7A)NoneNoneLMR A 401 (-4.5A)NoneLMR A 401 (-3.4A) | 1.11A | 1httC-3racA:26.3 | 1httC-3racA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HTT_D_HISD450_0 (HISTIDYL-TRNASYNTHETASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 8 / 12 | GLU A 95THR A 97ARG A 125GLN A 145GLU A 149GLY A 330GLY A 348ALA A 350 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)NoneLMR A 401 (-3.7A)LMR A 401 (-3.7A)LMR A 401 (-3.5A)LMR A 401 (-3.4A)LMR A 401 ( 3.9A) | 0.89A | 1httD-3racA:25.9 | 1httD-3racA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HTT_D_HISD450_0 (HISTIDYL-TRNASYNTHETASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 11 / 12 | GLU A 95THR A 97GLN A 145GLU A 149ARG A 306LEU A 308TYR A 310TYR A 311GLY A 330GLY A 348ALA A 350 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)LMR A 401 (-3.7A)LMR A 401 (-3.7A)NoneNoneNoneLMR A 401 (-4.5A)LMR A 401 (-3.5A)LMR A 401 (-3.4A)LMR A 401 ( 3.9A) | 0.56A | 1httD-3racA:25.9 | 1httD-3racA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HTT_D_HISD450_0 (HISTIDYL-TRNASYNTHETASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 8 / 12 | GLU A 95THR A 97GLU A 149LEU A 308TYR A 310TYR A 311GLY A 331GLY A 348 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)LMR A 401 (-3.7A)NoneNoneLMR A 401 (-4.5A)NoneLMR A 401 (-3.4A) | 1.08A | 1httD-3racA:25.9 | 1httD-3racA:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1I00_B_D16B409_1 (THYMIDYLATE SYNTHASE) |
4o7m | TRAP DICARBOXYLATETRANSPORTER, DCTPSUBUNIT (Shewanellaloihica) | 5 / 9 | PHE A 72ASP A 80GLY A 79PHE A 78ASN A 82 | NoneLMR A 401 ( 4.1A)NoneNoneNone | 1.35A | 1i00B-4o7mA:undetectable | 1i00B-4o7mA:21.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MJQ_B_SAMB200_0 (METHIONINE REPRESSOR) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 5 / 11 | GLU A 354GLU A 307LEU A 308GLU A 95PRO A 94 | GOL A 371 ( 4.8A)NoneNoneLMR A 401 (-3.4A)None | 1.39A | 1mjqA-3racA:undetectable1mjqB-3racA:undetectable | 1mjqA-3racA:13.481mjqB-3racA:13.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1R15_C_NCAC339_0 (ADP-RIBOSYL CYCLASE) |
5apa | ASPARTYL/ASPARAGINYLBETA-HYDROXYLASE (Homosapiens) | 3 / 3 | GLU A 617ASN A 618TRP A 625 | LMR A1760 ( 4.7A) NI A1759 ( 4.7A)LMR A1760 (-4.2A) | 1.25A | 1r15C-5apaA:undetectable | 1r15C-5apaA:22.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1R15_D_NCAD349_0 (ADP-RIBOSYL CYCLASE) |
5apa | ASPARTYL/ASPARAGINYLBETA-HYDROXYLASE (Homosapiens) | 3 / 3 | GLU A 617ASN A 618TRP A 625 | LMR A1760 ( 4.7A) NI A1759 ( 4.7A)LMR A1760 (-4.2A) | 1.23A | 1r15D-5apaA:undetectable | 1r15D-5apaA:22.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1R15_E_NCAE359_0 (ADP-RIBOSYL CYCLASE) |
5apa | ASPARTYL/ASPARAGINYLBETA-HYDROXYLASE (Homosapiens) | 3 / 3 | GLU A 617ASN A 618TRP A 625 | LMR A1760 ( 4.7A) NI A1759 ( 4.7A)LMR A1760 (-4.2A) | 1.25A | 1r15E-5apaA:undetectable | 1r15E-5apaA:22.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1R15_F_NCAF369_0 (ADP-RIBOSYL CYCLASE) |
5apa | ASPARTYL/ASPARAGINYLBETA-HYDROXYLASE (Homosapiens) | 3 / 3 | GLU A 617ASN A 618TRP A 625 | LMR A1760 ( 4.7A) NI A1759 ( 4.7A)LMR A1760 (-4.2A) | 1.22A | 1r15F-5apaA:undetectable | 1r15F-5apaA:22.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1T9W_A_NFNA6001_1 (ACRIFLAVINERESISTANCE PROTEIN B) |
5l2r | FUMARATE HYDRATASE (Leishmaniamajor) | 3 / 3 | SER A 217GLY A 216ARG A 350 | SF4 A 608 ( 4.5A)LMR A 601 (-3.1A)SF4 A 608 ( 4.5A) | 0.66A | 1t9wA-5l2rA:undetectable | 1t9wA-5l2rA:20.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UOF_A_PNNA1312_0 (DEACETOXYCEPHALOSPORIN C SYNTHETASE) |
5apa | ASPARTYL/ASPARAGINYLBETA-HYDROXYLASE (Homosapiens) | 5 / 11 | HIS A 679HIS A 725VAL A 727ARG A 735SER A 668 | NI A1759 ( 3.2A) NI A1759 ( 3.3A)LMR A1760 ( 4.9A)LMR A1760 (-2.9A)LMR A1760 (-2.7A) | 1.23A | 1uofA-5apaA:7.2 | 1uofA-5apaA:21.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1YVM_A_TMGA501_1 (METHIONINEAMINOPEPTIDASE) |
3tav | METHIONINEAMINOPEPTIDASE (Mycobacteroidesabscessus) | 5 / 7 | TYR A 69CYH A 77HIS A 86HIS A 191TRP A 234 | LMR A 271 ( 4.9A)LMR A 271 (-3.6A)LMR A 271 (-3.9A)LMR A 271 (-4.4A)None | 0.45A | 1yvmA-3tavA:36.9 | 1yvmA-3tavA:35.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2GVC_E_MMZE501_1 (MONOOXYGENASE) |
4o7m | TRAP DICARBOXYLATETRANSPORTER, DCTPSUBUNIT (Shewanellaloihica) | 3 / 3 | ASN A 216TYR A 243SER A 219 | LMR A 401 (-3.4A)LMR A 401 (-4.5A)None | 0.93A | 2gvcE-4o7mA:undetectable | 2gvcE-4o7mA:21.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HA4_B_ACHB603_0 (ACETYLCHOLINESTERASE) |
3tav | METHIONINEAMINOPEPTIDASE (Mycobacteroidesabscessus) | 4 / 7 | TYR A 69GLU A 217HIS A 184GLY A 183 | LMR A 271 ( 4.9A) MG A 266 (-2.7A) MG A 266 (-3.4A)None | 1.06A | 2ha4B-3tavA:undetectable | 2ha4B-3tavA:18.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y4N_B_PACB503_0 (PHENYLACETATE-COENZYME A LIGASE) |
5l2r | FUMARATE HYDRATASE (Leishmaniamajor) | 4 / 4 | SER A 347GLY A 248GLY A 492LYS A 491 | NoneNoneNoneLMR A 601 ( 2.6A) | 0.92A | 2y4nB-5l2rA:2.3 | 2y4nB-5l2rA:23.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZWE_B_DAHB98_1 (TYROSINASEMELC) |
5apa | ASPARTYL/ASPARAGINYLBETA-HYDROXYLASE (Homosapiens) | 5 / 11 | HIS A 690ILE A 739HIS A 679ASN A 618ASP A 616 | LMR A1760 (-3.8A)LMR A1760 (-4.0A) NI A1759 ( 3.2A) NI A1759 ( 4.7A)None | 1.16A | 2zweA-5apaA:undetectable2zweB-5apaA:undetectable | 2zweA-5apaA:21.882zweB-5apaA:17.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AF3_A_PAUA314_0 (PANTOTHENATE KINASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 4 / 6 | TYR A 333ARG A 332PHE A 316PHE A 349 | LMR A 401 (-4.1A)NoneNoneNone | 1.23A | 3af3A-3racA:undetectable | 3af3A-3racA:22.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DH0_A_SAMA220_1 (SAM DEPENDENTMETHYLTRANSFERASE) |
5apa | ASPARTYL/ASPARAGINYLBETA-HYDROXYLASE (Homosapiens) | 4 / 8 | ARG A 735ASP A 741GLN A 664GLU A 617 | LMR A1760 (-2.9A)NoneNoneLMR A1760 ( 4.7A) | 1.22A | 3dh0A-5apaA:undetectable | 3dh0A-5apaA:18.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3IJD_B_C2FB314_0 (UNCHARACTERIZEDPROTEIN) |
5l8x | TETRAHYDROMETHANOPTERINS-METHYLTRANSFERASESUBUNIT A (Methanocaldococcusjannaschii) | 5 / 12 | CYH A 52VAL A 30GLY A 50ILE A 72ILE A 67 | LMR A 201 (-4.6A)NoneNoneNoneNone | 1.02A | 3ijdB-5l8xA:undetectable | 3ijdB-5l8xA:18.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3R75_A_BEZA701_0 (ANTHRANILATE/PARA-AMINOBENZOATESYNTHASES COMPONENTI) |
3rrp | PROBABLE FUMARATEHYDRATASE FUM (Mycobacteroidesabscessus) | 5 / 12 | ILE A 361SER A 101GLY A 100SER A 104THR A 103 | NoneLMR A 468 (-2.9A)NoneNoneLMR A 468 (-2.9A) | 1.15A | 3r75A-3rrpA:undetectable | 3r75A-3rrpA:22.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3R75_B_BEZB701_0 (ANTHRANILATE/PARA-AMINOBENZOATESYNTHASES COMPONENTI) |
3rrp | PROBABLE FUMARATEHYDRATASE FUM (Mycobacteroidesabscessus) | 5 / 12 | ILE A 361SER A 101GLY A 100SER A 104THR A 103 | NoneLMR A 468 (-2.9A)NoneNoneLMR A 468 (-2.9A) | 1.16A | 3r75B-3rrpA:undetectable | 3r75B-3rrpA:22.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SI7_A_ACTA5_0 (CYSTIC FIBROSISTRANSMEMBRANECONDUCTANCEREGULATOR) |
4nf0 | PROBABLEC4-DICARBOXYLATE-BINDING PROTEIN (Pseudomonasaeruginosa) | 3 / 3 | LYS A 151SER A 93GLN A 173 | NoneLMR A 401 (-4.0A)LMR A 401 (-3.6A) | 1.38A | 3si7A-4nf0A:undetectable | 3si7A-4nf0A:21.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3T7S_A_SAMA300_0 (PUTATIVEMETHYLTRANSFERASE) |
5l2r | FUMARATE HYDRATASE (Leishmaniamajor) | 5 / 12 | GLY A 214GLY A 137ASP A 135ALA A 218ASN A 219 | SF4 A 608 (-3.4A)NoneLMR A 601 ( 3.6A)NoneLMR A 602 (-4.5A) | 0.93A | 3t7sA-5l2rA:undetectable | 3t7sA-5l2rA:19.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3T7S_B_SAMB300_0 (PUTATIVEMETHYLTRANSFERASE) |
5l2r | FUMARATE HYDRATASE (Leishmaniamajor) | 5 / 12 | GLY A 214GLY A 137ASP A 135ALA A 218ASN A 219 | SF4 A 608 (-3.4A)NoneLMR A 601 ( 3.6A)NoneLMR A 602 (-4.5A) | 0.94A | 3t7sB-5l2rA:undetectable | 3t7sB-5l2rA:19.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3T7S_D_SAMD300_0 (PUTATIVEMETHYLTRANSFERASE) |
5l2r | FUMARATE HYDRATASE (Leishmaniamajor) | 5 / 12 | GLY A 214GLY A 137ASP A 135ALA A 218ASN A 219 | SF4 A 608 (-3.4A)NoneLMR A 601 ( 3.6A)NoneLMR A 602 (-4.5A) | 0.87A | 3t7sD-5l2rA:undetectable | 3t7sD-5l2rA:19.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3V8V_B_SAMB802_0 (RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE L) |
3rrp | PROBABLE FUMARATEHYDRATASE FUM (Mycobacteroidesabscessus) | 5 / 12 | PHE A 240SER A 263SER A 137CYH A 58PRO A 237 | NoneNoneLMR A 468 (-2.7A)NoneNone | 1.39A | 3v8vB-3rrpA:undetectable | 3v8vB-3rrpA:21.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B9Z_A_ACRA1818_1 (ALPHA-GLUCOSIDASE,PUTATIVE, ADG31B) |
5apa | ASPARTYL/ASPARAGINYLBETA-HYDROXYLASE (Homosapiens) | 5 / 12 | ASP A 741GLU A 617ARG A 686ASP A 721PHE A 719 | NoneLMR A1760 ( 4.7A)NoneNoneNone | 1.35A | 4b9zA-5apaA:undetectable | 4b9zA-5apaA:13.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EB4_C_D16C402_1 (THYMIDYLATE SYNTHASE) |
4o7m | TRAP DICARBOXYLATETRANSPORTER, DCTPSUBUNIT (Shewanellaloihica) | 5 / 9 | PHE A 72ASP A 80GLY A 79PHE A 78ASN A 82 | NoneLMR A 401 ( 4.1A)NoneNoneNone | 1.39A | 4eb4C-4o7mA:undetectable | 4eb4C-4o7mA:21.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4G0V_D_MIXD101_1 (DNA TOPOISOMERASE2-BETA) |
4nf0 | PROBABLEC4-DICARBOXYLATE-BINDING PROTEIN (Pseudomonasaeruginosa) | 4 / 6 | ARG A 171GLY A 208GLN A 181MET A 307 | LMR A 401 (-2.9A)NoneNoneNone | 0.86A | 4g0vB-4nf0A:undetectable | 4g0vB-4nf0A:19.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4G0V_D_MIXD101_1 (DNA TOPOISOMERASE2-BETA) |
4o7m | TRAP DICARBOXYLATETRANSPORTER, DCTPSUBUNIT (Shewanellaloihica) | 4 / 6 | ARG A 176GLY A 213GLN A 186MET A 312 | LMR A 401 (-2.9A)NoneNoneNone | 0.91A | 4g0vB-4o7mA:undetectable | 4g0vB-4o7mA:16.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HTF_A_SAMA301_0 (S-ADENOSYLMETHIONINE-DEPENDENTMETHYLTRANSFERASE) |
5l2r | FUMARATE HYDRATASE (Leishmaniamajor) | 5 / 12 | GLY A 216GLY A 215GLY A 214SER A 345ALA A 250 | LMR A 601 (-3.1A)LMR A 601 ( 4.3A)SF4 A 608 (-3.4A)NoneLMR A 602 ( 3.8A) | 0.97A | 4htfA-5l2rA:undetectable | 4htfA-5l2rA:20.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HTF_B_SAMB301_0 (S-ADENOSYLMETHIONINE-DEPENDENTMETHYLTRANSFERASE) |
5l2r | FUMARATE HYDRATASE (Leishmaniamajor) | 5 / 12 | GLY A 216GLY A 215GLY A 214SER A 345ALA A 250 | LMR A 601 (-3.1A)LMR A 601 ( 4.3A)SF4 A 608 (-3.4A)NoneLMR A 602 ( 3.8A) | 0.99A | 4htfB-5l2rA:undetectable | 4htfB-5l2rA:20.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KR3_A_GLYA701_0 (GLYCINE--TRNA LIGASE) |
4jn7 | ENOLASE (Agrobacteriumtumefaciens) | 4 / 6 | ARG A 382GLU A 242GLU A 217SER A 243 | LMR A 402 (-4.0A)LMR A 402 ( 2.6A)NoneNone | 1.50A | 4kr3A-4jn7A:undetectable | 4kr3A-4jn7A:20.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MF6_A_BEZA303_0 (GLUTATHIONES-TRANSFERASE DOMAIN) |
4o7m | TRAP DICARBOXYLATETRANSPORTER, DCTPSUBUNIT (Shewanellaloihica) | 4 / 5 | THR A 46PRO A 47PHE A 199ASN A 153 | NoneNoneLMR A 401 (-3.6A)None | 1.20A | 4mf6A-4o7mA:undetectable | 4mf6A-4o7mA:27.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PFJ_B_ADNB502_2 (ADENOSYLHOMOCYSTEINASE) |
4nf0 | PROBABLEC4-DICARBOXYLATE-BINDING PROTEIN (Pseudomonasaeruginosa) | 4 / 6 | GLU A 210THR A 209GLN A 173ASN A 148 | NoneNoneLMR A 401 (-3.6A)None | 1.11A | 4pfjB-4nf0A:undetectable | 4pfjB-4nf0A:24.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RDX_A_HISA502_0 (HISTIDINE--TRNALIGASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 5 / 7 | THR A 97GLU A 149ARG A 306GLY A 330GLY A 348 | LMR A 401 (-3.5A)LMR A 401 (-3.7A)NoneLMR A 401 (-3.5A)LMR A 401 (-3.4A) | 1.20A | 4rdxA-3racA:26.4 | 4rdxA-3racA:27.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RDX_A_HISA502_0 (HISTIDINE--TRNALIGASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 4 / 7 | THR A 97GLU A 149GLY A 331GLY A 348 | LMR A 401 (-3.5A)LMR A 401 (-3.7A)NoneLMR A 401 (-3.4A) | 0.85A | 4rdxA-3racA:26.4 | 4rdxA-3racA:27.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RDX_A_HISA502_0 (HISTIDINE--TRNALIGASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 5 / 7 | THR A 97GLU A 149TYR A 311TYR A 333GLY A 348 | LMR A 401 (-3.5A)LMR A 401 (-3.7A)LMR A 401 (-4.5A)LMR A 401 (-4.1A)LMR A 401 (-3.4A) | 1.00A | 4rdxA-3racA:26.4 | 4rdxA-3racA:27.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZE1_A_X2NA602_2 (LANOSTEROL 14-ALPHADEMETHYLASE) |
3tav | METHIONINEAMINOPEPTIDASE (Mycobacteroidesabscessus) | 4 / 5 | VAL A 237TYR A 69ILE A 108THR A 250 | NoneLMR A 271 ( 4.9A)NoneNone | 1.22A | 4ze1A-3tavA:undetectable | 4ze1A-3tavA:18.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5CDN_G_EVPG2101_1 (DNA GYRASE SUBUNIT ADNA GYRASE SUBUNITB,DNA GYRASE SUBUNITB) |
4o7m | TRAP DICARBOXYLATETRANSPORTER, DCTPSUBUNIT (Shewanellaloihica) | 4 / 6 | SER A 236GLU A 235ARG A 176GLY A 213 | NoneNoneLMR A 401 (-2.9A)None | 0.77A | 5cdnA-4o7mA:undetectable5cdnB-4o7mA:undetectable | 5cdnA-4o7mA:20.975cdnB-4o7mA:18.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5E3I_A_HISA502_0 (HISTIDINE--TRNALIGASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 6 / 12 | ARG A 125GLN A 145GLU A 149TYR A 310GLY A 348ALA A 350 | NoneLMR A 401 (-3.7A)LMR A 401 (-3.7A)NoneLMR A 401 (-3.4A)LMR A 401 ( 3.9A) | 1.46A | 5e3iA-3racA:25.9 | 5e3iA-3racA:24.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5E3I_A_HISA502_0 (HISTIDINE--TRNALIGASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 6 / 12 | GLU A 95GLN A 145TYR A 310TYR A 333GLY A 330ALA A 350 | LMR A 401 (-3.4A)LMR A 401 (-3.7A)NoneLMR A 401 (-4.1A)LMR A 401 (-3.5A)LMR A 401 ( 3.9A) | 1.50A | 5e3iA-3racA:25.9 | 5e3iA-3racA:24.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5E3I_A_HISA502_0 (HISTIDINE--TRNALIGASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 8 / 12 | GLU A 95THR A 97ARG A 125GLN A 145GLU A 149TYR A 333GLY A 348ALA A 350 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)NoneLMR A 401 (-3.7A)LMR A 401 (-3.7A)LMR A 401 (-4.1A)LMR A 401 (-3.4A)LMR A 401 ( 3.9A) | 0.91A | 5e3iA-3racA:25.9 | 5e3iA-3racA:24.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5E3I_A_HISA502_0 (HISTIDINE--TRNALIGASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 10 / 12 | GLU A 95THR A 97GLN A 145GLU A 149LEU A 308TYR A 310TYR A 311GLY A 330GLY A 348ALA A 350 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)LMR A 401 (-3.7A)LMR A 401 (-3.7A)NoneNoneLMR A 401 (-4.5A)LMR A 401 (-3.5A)LMR A 401 (-3.4A)LMR A 401 ( 3.9A) | 0.44A | 5e3iA-3racA:25.9 | 5e3iA-3racA:24.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5E3I_A_HISA502_0 (HISTIDINE--TRNALIGASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 10 / 12 | GLU A 95THR A 97GLN A 145GLU A 149LEU A 308TYR A 310TYR A 311TYR A 333GLY A 348ALA A 350 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)LMR A 401 (-3.7A)LMR A 401 (-3.7A)NoneNoneLMR A 401 (-4.5A)LMR A 401 (-4.1A)LMR A 401 (-3.4A)LMR A 401 ( 3.9A) | 0.62A | 5e3iA-3racA:25.9 | 5e3iA-3racA:24.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5E3I_A_HISA502_0 (HISTIDINE--TRNALIGASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 6 / 12 | GLU A 95THR A 97GLN A 145TYR A 310GLY A 348ALA A 350 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)LMR A 401 (-3.7A)NoneLMR A 401 (-3.4A)LMR A 401 ( 3.9A) | 1.37A | 5e3iA-3racA:25.9 | 5e3iA-3racA:24.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5E3I_A_HISA502_0 (HISTIDINE--TRNALIGASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 7 / 12 | THR A 97GLU A 149LEU A 308TYR A 310TYR A 311GLY A 331GLY A 348 | LMR A 401 (-3.5A)LMR A 401 (-3.7A)NoneNoneLMR A 401 (-4.5A)NoneLMR A 401 (-3.4A) | 1.14A | 5e3iA-3racA:25.9 | 5e3iA-3racA:24.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5E3I_B_HISB502_0 (HISTIDINE--TRNALIGASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 6 / 11 | ARG A 125GLN A 145GLU A 149TYR A 310GLY A 348ALA A 350 | NoneLMR A 401 (-3.7A)LMR A 401 (-3.7A)NoneLMR A 401 (-3.4A)LMR A 401 ( 3.9A) | 1.48A | 5e3iB-3racA:26.2 | 5e3iB-3racA:24.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5E3I_B_HISB502_0 (HISTIDINE--TRNALIGASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 6 / 11 | GLN A 145GLU A 149TYR A 311TYR A 333GLY A 348ALA A 350 | LMR A 401 (-3.7A)LMR A 401 (-3.7A)LMR A 401 (-4.5A)LMR A 401 (-4.1A)LMR A 401 (-3.4A)LMR A 401 ( 3.9A) | 1.18A | 5e3iB-3racA:26.2 | 5e3iB-3racA:24.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5E3I_B_HISB502_0 (HISTIDINE--TRNALIGASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 8 / 11 | GLU A 95THR A 97ARG A 125GLN A 145GLU A 149TYR A 333GLY A 348ALA A 350 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)NoneLMR A 401 (-3.7A)LMR A 401 (-3.7A)LMR A 401 (-4.1A)LMR A 401 (-3.4A)LMR A 401 ( 3.9A) | 0.91A | 5e3iB-3racA:26.2 | 5e3iB-3racA:24.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5E3I_B_HISB502_0 (HISTIDINE--TRNALIGASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 9 / 11 | GLU A 95THR A 97GLN A 145GLU A 149TYR A 310TYR A 311GLY A 330GLY A 348ALA A 350 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)LMR A 401 (-3.7A)LMR A 401 (-3.7A)NoneLMR A 401 (-4.5A)LMR A 401 (-3.5A)LMR A 401 (-3.4A)LMR A 401 ( 3.9A) | 0.44A | 5e3iB-3racA:26.2 | 5e3iB-3racA:24.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5E3I_B_HISB502_0 (HISTIDINE--TRNALIGASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 9 / 11 | GLU A 95THR A 97GLN A 145GLU A 149TYR A 310TYR A 311TYR A 333GLY A 348ALA A 350 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)LMR A 401 (-3.7A)LMR A 401 (-3.7A)NoneLMR A 401 (-4.5A)LMR A 401 (-4.1A)LMR A 401 (-3.4A)LMR A 401 ( 3.9A) | 0.64A | 5e3iB-3racA:26.2 | 5e3iB-3racA:24.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5E3I_B_HISB502_0 (HISTIDINE--TRNALIGASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 6 / 11 | GLU A 95THR A 97GLN A 145TYR A 310GLY A 348ALA A 350 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)LMR A 401 (-3.7A)NoneLMR A 401 (-3.4A)LMR A 401 ( 3.9A) | 1.36A | 5e3iB-3racA:26.2 | 5e3iB-3racA:24.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5E3I_B_HISB502_0 (HISTIDINE--TRNALIGASE) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 7 / 11 | GLU A 95THR A 97GLU A 149TYR A 310TYR A 311GLY A 331GLY A 348 | LMR A 401 (-3.4A)LMR A 401 (-3.5A)LMR A 401 (-3.7A)NoneLMR A 401 (-4.5A)NoneLMR A 401 (-3.4A) | 1.16A | 5e3iB-3racA:26.2 | 5e3iB-3racA:24.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NNW_D_GCSD302_1 (25 KDA PROTEINELICITOR) |
3tav | METHIONINEAMINOPEPTIDASE (Mycobacteroidesabscessus) | 4 / 7 | GLY A 183HIS A 184ASP A 115HIS A 86 | None MG A 266 (-3.4A) MG A 269 ( 2.1A)LMR A 271 (-3.9A) | 0.78A | 5nnwD-3tavA:undetectable | 5nnwD-3tavA:15.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NO9_D_95ZD302_1 (25 KDA PROTEINELICITOR) |
3tav | METHIONINEAMINOPEPTIDASE (Mycobacteroidesabscessus) | 4 / 7 | GLY A 183HIS A 184ASP A 115HIS A 86 | None MG A 266 (-3.4A) MG A 269 ( 2.1A)LMR A 271 (-3.9A) | 0.77A | 5no9D-3tavA:undetectable | 5no9D-3tavA:15.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5O4Y_D_CCSD14_0 (PHE-MAA-ASN-PRO-HIS-LEU-SER-TRP-SER-TRP-9KK-9KK-ARG-CCS-GLY-NH2PROGRAMMED CELLDEATH 1 LIGAND 1) |
3rac | HISTIDINE-TRNALIGASE (Alicyclobacillusacidocaldarius) | 5 / 12 | LEU A 336ARG A 150GLY A 348VAL A 347ARG A 332 | NoneNoneLMR A 401 (-3.4A)NoneNone | 1.32A | 5o4yD-3racA:undetectable5o4yE-3racA:undetectable | 5o4yD-3racA:4.005o4yE-3racA:15.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Z0F_B_DAHB98_0 (MELCTYROSINASE) |
5apa | ASPARTYL/ASPARAGINYLBETA-HYDROXYLASE (Homosapiens) | 5 / 11 | HIS A 690ILE A 739HIS A 679ASN A 618ASP A 616 | LMR A1760 (-3.8A)LMR A1760 (-4.0A) NI A1759 ( 3.2A) NI A1759 ( 4.7A)None | 1.11A | 5z0fA-5apaA:undetectable5z0fB-5apaA:undetectable | 5z0fA-5apaA:16.515z0fB-5apaA:14.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Z0G_B_DAHB98_0 (MELCTYROSINASE) |
5apa | ASPARTYL/ASPARAGINYLBETA-HYDROXYLASE (Homosapiens) | 5 / 11 | HIS A 690ILE A 739HIS A 679ASN A 618ASP A 616 | LMR A1760 (-3.8A)LMR A1760 (-4.0A) NI A1759 ( 3.2A) NI A1759 ( 4.7A)None | 1.11A | 5z0gA-5apaA:undetectable5z0gB-5apaA:undetectable | 5z0gA-5apaA:16.515z0gB-5apaA:14.62 |